Optiver Holding B.V. Tg Therapeutics, Inc. Transaction History
Optiver Holding B.V.
- $5.14 Billion
- Q2 2024
A detailed history of Optiver Holding B.V. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Optiver Holding B.V. holds 2,495 shares of TGTX stock, worth $64,146. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,495Holding current value
$64,146% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TGTX
# of Institutions
298Shares Held
91.8MCall Options Held
1.9MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA13.7MShares$352 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$293 Million0.0% of portfolio
-
State Street Corp Boston, MA6.7MShares$172 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.65MShares$93.7 Million6.57% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.24MShares$83.4 Million0.07% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $3.73B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...